A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...

Scientists have found the first new antibiotic treatment for gonorrhoea since the 1990s amid fears over the rise of ...

Gepotidacine is not the only new oral antibiotic for gonorrhoea that researchers are exploring. Another, called zoliflodacin, ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...

Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...

The LATAM pain management drugs market was valued at $2,683.82 million in 2019, and is projected to reach $3,383.20 million by 2027, registering a CAGR of 3.5% from 2020 to 2027. The length of pain ...

Dr Rob Grundy has been appointed for a three-year term as the new northern co-chair of the US-Ireland R&D Partnership ...

In a significant breakthrough in the fight against antibiotic-resistant sexually transmitted infections (STIs), a new oral pill, gepotidacin, has shown promising results in combating drug-resistant ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk ...

In spring 2021, my family sold a big lump of GSK shares. Four years later, we have no regrets. Indeed, with the GSK share price stumbling, we may buy soon.